Monopar Therapeutics Reports Second Quarter 2025 Financial Results and Recent Developments

Go back to Monopar Therapeutics Reports Second Quarter 2025 Financial Results and Recent Developments
(NASDAQ: MNPR) Delayed: 113.49 +3.53 (3.21%)
Previous Close $109.96    52 Week High
Open $113.84    52 Week Low
Day High $113.84    P/E N/A 
Day Low $113.26    EPS
Volume 3,416